• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19

    10/19/22 8:17:52 AM ET
    $AAPL
    $ABT
    $ACI
    $AMZN
    Computer Manufacturing
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAPL alert in real time by email

    Reuters

    US Lawmakers Plan Hearing On Kroger, Albertsons' $25B Merger

    • U.S. senators inspecting antitrust issues are set to hold a hearing on grocery chain Kroger Co's (NYSE:KR) plan to acquire rival Albertsons Companies Inc (NYSE:ACI) in a $25 billion deal.
    • Chair of the Senate Judiciary Committee antitrust panel, Democratic Senator Amy Klobuchar, and Republican Senator Mike Lee expressed serious concerns about the merger.

    Amazon Fined By Russia For Failing To Remove Content About Drug Use, Suicide

    • Amazon.com Inc (NASDAQ:AMZN) was handed a fine by a court in Russia for failing to remove proscribed content on Tuesday.
    • A Moscow court fined the Jeff Bezos-founded conglomerate 4 million rubles ($65,000) for failing to remove content related to drug use and suicide without elaborating on specifics.

    US Sends Gilead's COVID-19 Antiviral To Safeguard Health Workers In Uganda Ebola Outbreak

    • The U.S. sent Gilead Sciences Inc's (NASDAQ: GILD) remdesivir and Mapp Biopharmaceutical Inc's experimental Ebola antibody drug MBP134 to Uganda as a response to the Ebola outbreak.
    • The medicines will help safeguard healthcare workers responding to an outbreak that has infected 60 people and killed 44.

    Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug

    • The French court is reportedly investigating Germany-based Merck KGaA (OTC:MKKGY), saying the company provided misleading information regarding its thyroid drug product Levothyrox.
    • The ruling did not concern the new formula for the Levothyrox product but how the company provided information when changing from the old to the new formula.

    Amazon Earns Another Breather As Workers Dump NY Union

    • Amazon.com Inc workers rejected organizing a New York state warehouse by a nearly two-to-one margin serving as another defeat to the countrywide labor union activism.
    • It marked Amazon workers' third rejection in forming, including at a second New York City facility and another in Alabama.
    • Amazon recently raised its U.S. average starting pay for front-line staff.
    • Michael Pachter, an analyst at Wedbush Securities, said, "If workers feel they are fairly paid, they are less likely to unionize."

    Singapore Fashion Brand Lovebonito Plans First US Store In 2023, Eyes IPO

    • Singapore's Direct-to-Consumer retailer Lovebonito Holdings is planning to open its first U.S. brick-and-mortar store in 2023.
    • Love, Bonito female fashion brand is backed by investors, including Chinese buyout firm Primavera Capital Group.
    • "The U.S is really one of the big bet markets for us that we want to double down on," the report quoted CEO Dione Song.

    Bloomberg

    Celsius Faces Federal Investigations In 40 States For Suspending Crypto Withdrawals

    • Cryptocurrency lender Celsius Network (CRYPTO: CEL/USD), which declared bankruptcy earlier this year, told a U.S. bankruptcy court that it is facing several "federal investigations."
    • Celsius has been subject to enforcement proceedings or investigations in at least 40 states, it told the Southern District of New York.

    SurveyMonkey Parent Momentive Global Shares Jump Premarket On Takeover Speculation

    • SurveyMonkey owner Momentive Global Inc (NASDAQ:MNTV) explored a sale after getting takeover interest.
    • Momentive is working with a financial adviser.
    • Zendesk Inc (NYSE:ZEN) agreed to buy Momentive in 2021 for nearly $4 billion in an all-stock deal.

    CNBC

    Rolls-Royce Chief Touts Its Debut EV As 'Most Perfect' Product; Bags Massive Orders Even Before Launch

    • More than 300 U.S. buyers have already put down deposits for Rolls Royce Holdings plc's (OTC:RYCEY) debut electric vehicle before its unveiling on October 18.
    • Rolls-Royce CEO Torsten Muller-Otvos told CNBC that the buyers visited the company's headquarters in Goodwood, England, over the past two weeks to get a sneak peek at the Spectre, which had a starting price tag of $413,000.
    • "Spectre is the most perfect product that Rolls Royce has ever produced," Muller-Otvos said.

    Target Stores To Sell Caraway's Kitchenware Products

    • Target Corp (NYSE:TGT) will sell kitchenware and home goods brand Caraway's products in 350 stores starting this week.
    • New York-based Caraway is a direct-to-consumer company whose goods are already available on Target's website.
    • The latest move to sell products in Target's brick-and-mortar stores is expected to widen the customer base and drive growth.

    Financial Times

    Amazon Braces For UK's Insurance Market With Latest Offering

    • Amazon.com Inc launched a portal for buying insurance in the U.K., challenging veteran price comparison sites.
    • Amazon launched a home insurance comparison service a week after Apple Inc announced new high-yield savings account with Goldman Sachs Group Inc (NYSE:GS).

    Benzinga

    SpaceX Launches' Starlink Aviation' For In-Flight Connectivity, Elon Musk Says It'll Feel Like 'Accessing Internet At Home'

    • Elon Musk-owned SpaceX's Starlink has launched a new service allowing air travelers to stay connected while on a flight.
    • Starlink announced "Starlink Aviation," which, according to the company, will provide high-speed, low-latency, in-flight internet with connectivity across the globe.
    • The service will deliver up to 350 Mbps to each plane, allowing all passengers to access streaming-capable internet at the same time, Starlink said.

    Netflix' Seriously Exploring' Cloud Gaming Space As It Launches Another Studio

    • Netflix Inc (NASDAQ:NFLX) plans to dive deep into gaming and is considering its cloud gaming platform.
    • At the TechCrunch Disrupt conference on Tuesday, the company's VP of games, Mike Verdu, said that the streaming giant is "seriously exploring a cloud gaming offering so that we can reach members on TVs and PCs."

    As Apple Refreshes iPad Models, 4K TV Ahead Of Holiday Season, Analysts Weigh In On Pricing And Features

    • Apple Inc (NASDAQ:AAPL) decided to do away with a launch event and announced another batch of new hardware products on Tuesday via press releases. The launches aligned with what Bloomberg's Mark Gurman reported on Saturday.
    • Commenting on the launches, Loup Funds' Gene Munster noted that it had been four years since Apple updated the iPad and Pro before the holiday season. He added that these products account for about 6% of overall revenue.

    Apple Cuts iPhone 14 Plus Production To Tap Demand For Premium iPhone Pro Models

    • Apple Inc slashed the iPhone 14 Plus production less than two weeks after its debut.
    • Apple has told at least one manufacturer in China to immediately halt production of iPhone 14 Plus components while its procurement team reevaluated demand for the product.
    • Apple had positioned the iPhone 14 Plus as a cheaper alternative to its more expensive iPhone Pro models equipped with a large screen.

    Consumers Should Be Ready For Further Price Increases, Nestle's Chief Executive Says

    • Nestle SA's (OTC:NSRGY) (OTC:NSRGF) Chief Executive Officer Mark Schneider said inflation will remain an issue in 2023.
    • "We are seeing huge upward pressure on energy, some agricultural commodities, and transportation costs."
    • Schneider said wages would add to cost pressure next year.

    Aramex Snaps This Cross-border e-Commerce Enabler Platform For $265M

    • Aramex PJSC, a leading global provider of comprehensive logistics and transportation solutions, obtained all necessary regulatory approvals and completed the acquisition of Access USA Shipping, LLC (MyUS), a global technology-driven platform enabling cross-border e-Commerce, for an all-cash consideration of $265 million.
    • The acquisition will further strengthen Aramex's cross-border express business.
    • This transaction will likely immediately value accretive for Aramex.

    CMA Orders Meta To Sell Off Giphy As The Deal Failed To Satisfy Antitrust Concerns

    • The Competition and Markets Authority has found that Meta Platform Inc's (NASDAQ:META) takeover of Giphy could allow Meta to limit other social media platforms' access to GIFs, making those sites less attractive to users and less competitive.
    • It also found that the deal has removed Giphy as a potential challenger in the U.K. display advertising market, preventing U.K. businesses from benefiting from innovation in this market.

    Infant Formula Fiasco Weighs On Abbott's Q3 Earnings, Still It Raised FY22 EPS Guidance

    • Abbott Laboratories (NYSE:ABT) has reported Q3 FY22 adjusted EPS of $1.15, down 17.9% Y/Y, better than the consensus of $0.94.
    • Q3 sales of $10.4 billion decreased 4.7% on a reported basis and increased 1.3% on an organic basis, beating the consensus of $9.64 billion.
    • Q3 sales were negatively impacted by declines in COVID-19 testing-related sales and a manufacturing stoppage of certain infant formula products.
    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $ABT
    $ACI
    $AMZN

    CompanyDatePrice TargetRatingAnalyst
    Gilead Sciences Inc.
    $GILD
    2/20/2026$155.00Equal Weight
    Barclays
    Gilead Sciences Inc.
    $GILD
    2/11/2026$140.00 → $170.00Buy
    Needham
    Apple Inc.
    $AAPL
    2/10/2026$325.00 → $340.00Outperform
    Bernstein
    Amazon.com Inc.
    $AMZN
    2/6/2026$300.00 → $280.00Buy
    Monness Crespi & Hardt
    Amazon.com Inc.
    $AMZN
    2/6/2026$175.00Buy → Neutral
    DA Davidson
    Amazon.com Inc.
    $AMZN
    2/2/2026$300.00 → $315.00Mkt Outperform
    Citizens JMP
    Apple Inc.
    $AAPL
    1/30/2026$315.00 → $325.00Overweight
    Analyst
    Apple Inc.
    $AAPL
    1/30/2026$230.00 → $239.00Underweight
    Barclays
    More analyst ratings

    $AAPL
    $ABT
    $ACI
    $AMZN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-6) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215973, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-8) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215974, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAPL
    $ABT
    $ACI
    $AMZN
    SEC Filings

    View All

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/20/26 5:24:43 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    Abbott Laboratories filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - ABBOTT LABORATORIES (0000001800) (Filer)

    2/20/26 4:17:51 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/20/26 4:13:19 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $AAPL
    $ABT
    $ACI
    $AMZN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Gilead Sciences with a new price target

    Barclays initiated coverage of Gilead Sciences with a rating of Equal Weight and set a new price target of $155.00

    2/20/26 8:24:53 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Needham reiterated coverage on Gilead Sciences with a new price target

    Needham reiterated coverage of Gilead Sciences with a rating of Buy and set a new price target of $170.00 from $140.00 previously

    2/11/26 7:05:53 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Bernstein reiterated coverage on Apple with a new price target

    Bernstein reiterated coverage of Apple with a rating of Outperform and set a new price target of $340.00 from $325.00 previously

    2/10/26 7:51:49 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $ABT
    $ACI
    $AMZN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hess John B bought $1,997,584 worth of shares (3,904 units at $511.68) (SEC Form 4)

    4 - GOLDMAN SACHS GROUP INC (0000886982) (Issuer)

    4/17/25 4:06:04 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $AAPL
    $ABT
    $ACI
    $AMZN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Exact Sciences Stockholders Approve Acquisition by Abbott

    Exact Sciences Corporation (NASDAQ:EXAS) ("Exact Sciences"), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (NYSE:ABT) at the special meeting of stockholders held earlier today. At the special meeting, preliminary results showed that more than 99% of the votes cast, representing approximately 67% of the total outstanding shares of Exact Sciences common stock as of the January 9, 2026 record date for the special meeting, were voted in favor of the transaction. Final voting results from the special meeting will be reported by Exact Sciences in a Current Report on Form 8‑

    2/20/26 4:05:00 PM ET
    $ABT
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities

    Abbott declares 409th consecutive quarterly dividend

    ABBOTT PARK, Ill., Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share. This marks the 409th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2026, to shareholders of record at the close of business on April 15, 2026.Abbott has increased its dividend payout for 54 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio o

    2/20/26 11:38:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Uranium Demand Continues to Rise as AI Power Demand Rewrites the Nuclear Playbook

    Issued on behalf of Eagle Energy Metals Corp.Equity-Insider.com News CommentaryVANCOUVER, BC, Feb. 19, 2026 /CNW/ -- U.S. data center electricity demand is projected to grow from 176 terawatt hours to as high as 580 terawatt hours by 2028, with AI-driven consumption outpacing available grid capacity in multiple regions[1]. Spot uranium prices rose 25% in January 2026, surpassing $100 per pound for the first time in two years (before correcting back down to a still-high $89), as institutional buyers accelerated physical accumulation of the fuel[2]. These dynamics are converging around Spring Valley Acquisition Corp. II (OTC:SVIIF), Oklo (NYSE:OKLO), Meta Platforms (NASDAQ:META), NANO Nuclear

    2/19/26 9:00:00 AM ET
    $META
    $NNE
    $OKLO
    Computer Software: Programming Data Processing
    Technology
    Electric Utilities: Central
    Utilities

    $AAPL
    $ABT
    $ACI
    $AMZN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Legal Officer Mahoney Curtis J.

    4 - Meta Platforms, Inc. (0001326801) (Issuer)

    2/20/26 9:37:38 PM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    SEC Form 4 filed by President and Vice Chairman Powell Dina H.

    4 - Meta Platforms, Inc. (0001326801) (Issuer)

    2/20/26 9:33:20 PM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    Chief Technology Officer Bosworth Andrew sold $5,106,082 worth of shares (8,089 units at $631.24), decreasing direct ownership by 74% to 2,841 units (SEC Form 4)

    4 - Meta Platforms, Inc. (0001326801) (Issuer)

    2/20/26 6:34:29 PM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    $AAPL
    $ABT
    $ACI
    $AMZN
    Leadership Updates

    Live Leadership Updates

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Kroger Appoints Greg Foran as Chief Executive Officer

    Accomplished Food Retail Leader Brings Strong Experience as Company Advances Its Growth Strategy Ron Sargent Continues as Chairman of Kroger's Board of Directors  CINCINNATI, Feb. 9, 2026 /PRNewswire/ -- The Kroger Co. (NYSE:KR) today announced its Board of Directors appointed Greg Foran as Chief Executive Officer, effective immediately. Foran will also join Kroger's Board of Directors and succeeds Ron Sargent, who served as interim CEO since March 2025. This announcement follows an extensive search process conducted by the Board to identify an innovative retail leader with a strong track record of execution at scale.

    2/9/26 7:30:00 AM ET
    $KR
    Food Chains
    Consumer Staples

    $AAPL
    $ABT
    $ACI
    $AMZN
    Financials

    Live finance-specific insights

    View All

    Abbott declares 409th consecutive quarterly dividend

    ABBOTT PARK, Ill., Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share. This marks the 409th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2026, to shareholders of record at the close of business on April 15, 2026.Abbott has increased its dividend payout for 54 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio o

    2/20/26 11:38:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options

    – Pivotal Phase 3 Findings Support the Potential of a Novel Single-Tablet Combination of Bictegravir and Lenacapavir for HIV Treatment – – Latest Data from the PURPOSE Program Further Demonstrates the Safety and Efficacy Profile of Twice-Yearly Lenacapavir for HIV Prevention – Gilead Sciences, Inc. (NASDAQ:GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI 2026) being held from February 22-25 in Denver, Colorado. Focusing on expanding therapeutic options to meet the diverse needs of communities af

    2/17/26 8:30:00 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Meta Announces Quarterly Cash Dividend

    MENLO PARK, Calif., Feb. 12, 2026 /PRNewswire/ -- The Meta Platforms, Inc. (NASDAQ:META) board of directors today declared a quarterly cash dividend of $0.525 per share of the company's outstanding Class A common stock and Class B common stock, payable on March 26, 2026 to stockholders of record as of the close of business on March 16, 2026. About MetaMeta is building the future of human connection, powered by artificial intelligence and immersive technologies. When Facebook launched in 2004, it changed the way people connect. Apps like Messenger, Instagram, and WhatsApp furth

    2/12/26 4:05:00 PM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    $AAPL
    $ABT
    $ACI
    $AMZN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Target Corporation

    SC 13G/A - TARGET CORP (0000027419) (Subject)

    11/13/24 12:52:42 PM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Goldman Sachs Group Inc.

    SC 13G/A - GOLDMAN SACHS GROUP INC (0000886982) (Filed by)

    11/8/24 5:34:28 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Subject)

    11/8/24 4:33:15 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary